Staphylococcus

 Overview of Staphylococcus

The genus Staphylococcus consists of Gram-positive, spherical cells (cocci) that characteristically divide in multiple planes to form irregular, grape-like clusters. They are non-motile, non-spore-forming, and typically facultative anaerobes.

From a diagnostic perspective, the definitive starting point to differentiate Staphylococcus from Streptococcus is the catalase test, as all clinically significant staphylococci are catalase-positive.

Major Clinically Significant Species

The genus is broadly categorized into two main groups based on the production of the coagulase enzyme, which clots plasma:

1. Coagulase-Positive Staphylococci (CoPS)

Staphylococcus aureus: The most pathogenic species. It produces staphyloxanthin, a carotenoid pigment that gives its colonies a characteristic golden-yellow color on solid media. It is a major cause of both superficial skin infections and deep-seated systemic infections.

2. Coagulase-Negative Staphylococci (CoNS)

Staphylococcus epidermidis: Part of the normal skin flora. It is an opportunistic pathogen heavily associated with biofilms on medical devices like catheters, prosthetic valves, and joint replacements.

Staphylococcus saprophyticus: Notably resistant to novobiocin. It is a primary cause of uncomplicated community-acquired urinary tract infections (UTIs) in young, sexually active females.

Laboratory Identification

A systematic bench approach relies on morphological characteristics, selective growth media, and key biochemical reactions:

Cultural Characteristics

Blood Agar: S. aureus forms smooth, round, raised, opaque colonies (often golden-yellow) typically surrounded by a zone of complete clearing (beta-hemolysis). CoNS species generally present as white, non-hemolytic colonies.

Mannitol Salt Agar (MSA): A selective and differential medium containing 7.5% NaCl, which inhibits most other organisms. S. aureus ferments mannitol, turning the phenol red indicator from pink to yellow. CoNS species typically grow but do not ferment mannitol, leaving the medium pink.

Primary Biochemical Differentiation

Test

S. aureus

S. epidermidis

S. saprophyticus

Catalase

Positive (+)

Positive (+)

Positive (+)

Coagulase (Slide/Tube)

Positive (+)

Negative (-)

Negative (-)

Mannitol Fermentation

Positive (+)

Negative (-)

Variable (usually -)

Novobiocin Susceptibility

Susceptible

Susceptible

Resistant

Pathogenesis and Clinical Significance

Staphylococcus aureus

Virulence Factors:

Surface components: Protein A (binds the Fc portion of IgG, inhibiting phagocytosis), fibronectin-binding proteins.

Enzymes: Coagulase, hyaluronidase, staphylokinase, lipases.

Toxins: Hemolysins (\alpha, \beta, \gamma, \delta), Leukocidin (Panton-Valentine leukocidin), Enterotoxins (A–E, causing food poisoning), Exfoliatin (scalded skin syndrome), and Toxic Shock Syndrome Toxin-1 (TSST-1).

Clinical Conditions: Impetigo, folliculitis, furuncles, carbuncles, wound infections, deep abscesses, osteomyelitis, infective endocarditis, and bacteremia.

Coagulase-Negative Staphylococci (CoNS)

Biofilm Production: S. epidermidis produces an extracellular polysaccharide slime layer (slime/biofilm) that allows adherence to foreign bodies and protects the bacteria from both antibiotics and host immune defenses.

Antimicrobial Resistance

Resistance patterns in this genus pose significant challenges for clinical management:

\beta-lactamase Production: Over 90% of staphylococcal isolates produce \beta-lactamase, rendering them resistant to natural penicillins (like penicillin G).

MRSA (Methicillin-Resistant S. aureus): Mediated by the mecA gene, which encodes an altered penicillin-binding protein (PBP2a). PBP2a has a low affinity for \beta-lactam antibiotics, causing resistance to all penicillins, cephalosporins (except 5th generation), and carbapenems.

VRSA/VISA: Vancomycin-resistant and vancomycin-intermediate strains, though still rare, represent critical resistance threats.